We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

This penny stock is up 15% in 1 month. Should I buy?

This penny stock is in the limelight. The company has gone through a four-year transformation. But is now the right time for me to buy?

| More on:
A graph made of neon tubes in a room

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Mitie (LSE: MTO) is a penny stock that has been rising. During the last month the shares have risen 15% and they’re up more than 85% during the last year.

Of course, past performance isn’t an indication of future returns. But I commented on Mitie being a penny stock that I’d buy in June. And I still hold this view. The company reported its full-year results last week. And the numbers look promising.

Should you buy Mitie Group Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

The results

The 2021 financial year marked the end of Mitie’s four-year transformation. And the company showed resilience through the pandemic. Revenue increased by 19% to £2.6bn. This included a four-month contribution from its Interserve acquisition.

But operating profits fell. The company said that the additional profit from contract wins, inclusion of Interserve and associated £6.2m of synergies was “more than offset by the impact of Covid on trading, the ending of certain profitable contracts in the prior year and the reinstatement of incentives and share based payments (which were waived last year to preserve our financial strength)”.

Order book

Yet I like that Mitie’s order book looks strong. As of the end of March, it stood at £7.2bn, which included £3.2bn from Interserve. This offers revenue stability and transparency, which is something I look for when analysing a company.

What is encouraging is that the FTSE 250 firm has managed to either win or renew contracts worth £1.3bn. To me, this highlights that Mitie’s clients think it’s doing a good job, otherwise they wouldn’t have extended their contracts. It also reconfirms the company’s market position and makes it stand out from its competitors.

Mitie acquired Interserve in November last year. Most of the acquisition’s order book has contracts that average 15 years in length. What I also like is how Mitie has managed to renew or extend all of Interserve’s major contracts that came up for renewal in the four-month period under ownership. This should prove to be positive for the penny stock in the long term.

Net debt

Mitie is also improving its financial position. The net debt position at the year-end stood at £86.7m compared to the previous year’s £153m. Clearly, a rights issue and refinancing of its credit facility have helped.

But it’s good to see that the company’s liabilities are falling and heading in the right direction. I think the shares could rise further on the back on of an improving balance sheet.

Risks

It’s clear that Mitie was hit by Covid-19. While restrictions are somewhat easing, I’m not suggesting the pandemic is completely over. The coronavirus crisis could continue to impact profitability just as it did in its 2021 financial year. Another period of low profits may prove to be negative for the shares.

But I think things look promising for this penny stock. It’s winning or renewing contracts while the Interserve acquisition seems to be integrating well and is starting to pay off. The four-year transformation plan has come to an end, so investors should start to see the benefits. I’d buy Mitie shares today.

Nadia Yaqub has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Up nearly 1,400% in 5 years! But are Rolls-Royce shares still secretly undervalued?

After skyrocketing, Rolls-Royce shares are now near an all-time high, but could the engineering giant still have more room to…

Read more »

Happy senior couple hugging and enjoying retirement at home
Investing Articles

By mid-2027, analysts expect £5,000 in Barclays shares to be worth…

Barclays shares have outperformed the FTSE 100 by a wide margin over the last year. And City analysts expect to…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

Near 5-year lows, here’s what the experts say about the Diageo share price

Ben McPoland's questioning his sanity after investing in Diageo. Where do institutional analysts see its share price heading over the…

Read more »

British Airways cabin crew with mobile device
Investing Articles

Up 165% but still with a P/E of 7.9. Is the IAG share price a generational bargain?

The IAG share price has been on fire for the last two years, delivering some of the biggest returns in…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Here’s the latest Vodafone share price forecasts for 2027

Up 35% in 12 months, the Vodafone share price is beating the stock market right now, but can this momentum…

Read more »